The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index; none of the 56 sources its claims cite is checked for support yet.
Efficacy and Safety of Axiostat® Hemostatic Dressing in Aiding Manual Compression Closure of the Femoral Arterial Access Site in Patients Undergoing Endovascular Treatments: A Preliminary Clinical Experience in Two Centers
Open accessAbstract
Background: Hemostasis of the femoral arterial access site by manual compression or a vascular closure device is critical to the safe completion of any endovascular procedure. Previous investigations evaluated the hemostatic efficacy at the radial access site of some chitosan-based hemostatic pads. This study aims to assess the efficacy and safety of a new chitosan-based hemostatic dressing, namely Axiostat®, in aiding manual compression closure of the femoral arterial access site in patients undergoing endovascular treatments. Furthermore, the outcomes were compared with evidence on manual compression alone and vascular closure devices. Methods: This investigation is a two-center retrospective analysis of 120 consecutive patients who had undergone, from July 2022 to February 2023, manual compression closure of the femoral arterial access site aided by the Axiostat® hemostatic dressing. Endovascular procedures performed with introducer sheaths ranging from 4 Fr to 8 Fr were evaluated. Results: Primary technical success was achieved in 110 (91.7%) patients, with adequate hemostasis obtained in all cases of prolonged manual compression requirements. The mean time-to-hemostasis and time-to-ambulation were 8.9 (±3.9) and 462 (±199) minutes, respectively. Clinical success was achieved in 113 (94.2%) patients, with bleeding-related complications noted in 7 (5.8%) patients. Conclusions: Manual compression aided by the Axiostat® hemostatic dressing is effective and safe in achieving hemostasis of the femoral arterial access site in patients undergoing endovascular treatment with a 4–8 Fr introducer sheath.
Overview
CoChat Summary
TL;DR
In this two-center retrospective series of 120 patients, manual compression aided by the Axiostat® hemostatic dressing after femoral arterial access with 4–8 Fr sheaths achieved primary technical success in 91.7% and clinical success in 94.2%, with bleeding-related vascular access site complications in 5.8%. The authors conclude the approach is effective and safe but call for larger randomized controlled trials because of the lack of a control group.
Key findings
- Primary technical success was achieved in 110/120 patients (91.7%); secondary technical success was 100%. Mean time-to-hemostasis was 8.9 (±3.9) minutes and mean time-to-ambulation was 462 (±199) minutes.
- Clinical success was achieved in 113/120 patients (94.2%); bleeding-related VASCs occurred in 7 patients (5.8%). The overall VASC rate was 8.3%, comprising 2 hematomas (1.7%), 5 pseudoaneurysms (4.1%), and 3 dissections (2.5%). No major bleeding events occurred; only CIRSE grade 2 or 3 events occurred, and no SVS major (grade 3) VASCs were noted. One pseudoaneurysm required US-guided percutaneous thrombin injection.
- In subgroup comparison, primary technical success was significantly higher with 4–6 Fr sheaths than with 7–8 Fr sheaths (97.8% vs. 71.4%; p < 0.001), while intraoperative thrombolytic agent use was significantly higher in the 7–8 Fr group (25% vs. 1.1%; p < 0.001). No statistically significant differences were observed between groups for VASCs or bleeding-related VASCs.
- Simple logistic regression identified coagulopathy (p = 0.036) and systolic pressure (p = 0.007) as significant single predictors of bleeding-related VASCs; multiple logistic regression found coagulopathy as the exception (p = 0.029), with the paper noting an average increase of 4.55 in the log odds of bleeding-related VASC occurrence for the coagulopathy group.
Methods
- Two-center retrospective analysis of 120 consecutive patients who underwent manual compression closure of the femoral arterial access site aided by the Axiostat® hemostatic dressing from July 2022 to February 2023, after endovascular treatment with introducer sheaths ranging from 4 Fr to 8 Fr.
- Protocol: Axiostat® was applied on the skin access site instead of cotton gauze; manual compression was performed for 7 minutes for 4–6 Fr sheaths and 10 minutes for 7–8 Fr sheaths, with continuation if needed. A pressure dressing was maintained for 6 hours (4–6 Fr) or 12 hours (7–8 Fr); color-coded duplex sonography was performed before discharge, and telephone follow-up occurred at 30 days.
- Outcomes included primary technical success, clinical success, secondary technical success, time-to-hemostasis, time-to-ambulation, and VASC rate. Analysis used the modified intention-to-treat population, SPSS and R/R Studio, descriptive statistics, subgroup comparisons, t-test/Mann–Whitney/chi-squared/Fisher exact tests, and simple and multiple logistic regression with p < 0.05 considered significant.
Limitations
- The paper states the main limitations as lack of randomization, absence of a control group, and small population size; it also notes the preliminary nature of the experience, heterogeneity of treatments and introducer sheaths, difficulty interpreting periprocedural anticoagulant therapy as a possible confounder, retrospective design providing inferior evidence, and scarcity of literature for comparison.
- Evident from the text: the single-arm design means no direct comparison with manual compression alone or vascular closure devices, and the 30-day telephone follow-up may not capture later access-site complications.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
0 Valid · 0 Not valid · 20 Not checked · 53 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Clinical success was achieved in 113 (94.2%) patients”
- Also stated in: § 3.3. Outcomes · plain
“Clinical success was achieved in 113 (94.2%) patients”
§ Efficacy and Safety of Axiostat® Hemostatic Dressing in Aiding Manual Compression Closure of the Femoral Arterial Access Site in Patients Undergoing Endovascular Treatments: A Preliminary Clinical Experience in Two Centers > Abstract
plainn = 120- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 3.3. Outcomes · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Simple logistic regression analyses showed that coagulopathy (p = 0.036) and systolic pressure (p = 0.007) were significant single predictors of bleeding-related VASC occurrence.”
§ Efficacy and Safety of Axiostat® Hemostatic Dressing in Aiding Manual Compression Closure of the Femoral Arterial Access Site in Patients Undergoing Endovascular Treatments: A Preliminary Clinical Experience in Two Centers > 3. Results > 3.5. Predictors of Bleeding-Related VASCs
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“coagulopathy (11 vs. 1 patients; p = 0.291)”
§ Efficacy and Safety of Axiostat® Hemostatic Dressing in Aiding Manual Compression Closure of the Femoral Arterial Access Site in Patients Undergoing Endovascular Treatments: A Preliminary Clinical Experience in Two Centers > 3. Results > 3.4. Sheath Size 4–6 Fr vs. Sheath Size 7–8 Fr
plainSingle case- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Simple logistic regression analyses showed that coagulopathy (p = 0.036) and systolic pressure (p = 0.007) were significant single predictors of bleeding-related VASC occurrence.”
§ Efficacy and Safety of Axiostat® Hemostatic Dressing in Aiding Manual Compression Closure of the Femoral Arterial Access Site in Patients Undergoing Endovascular Treatments: A Preliminary Clinical Experience in Two Centers > 3. Results > 3.5. Predictors of Bleeding-Related VASCs
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“antiplatelet or anticoagulant therapy (51 vs. 19 patients; p = 0.343)”
§ Efficacy and Safety of Axiostat® Hemostatic Dressing in Aiding Manual Compression Closure of the Femoral Arterial Access Site in Patients Undergoing Endovascular Treatments: A Preliminary Clinical Experience in Two Centers > 3. Results > 3.4. Sheath Size 4–6 Fr vs. Sheath Size 7–8 Fr
plainn = 19- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
39 more claims
Create a free account to see all 73 claims and to verify the 55 references still open.
- It may state two separate claims as one. 14
- Probably not a substantial claim. 18
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The results showed that primary technical success was achieved in 91.7% of patients, with adequate hemostasis achieved after around 8.9 (±3.9) min and ambulation occurring after 462 (±199) min.”
From Chitosan Hemostatic Dressings: Properties and Surgical Applications (2024) · cites this paper as [71]
In the citing paper
“The results showed that primary technical success was achieved in 91.7% of patients, with adequate hemostasis achieved after around 8.9 (±3.9) min and ambulation occurring after 462 (±199) min.”
From Chitosan Hemostatic Dressings: Properties and Surgical Applications (2024) · cites this paper as [71]
In the citing paper
“Bleeding-related complications were observed in only 5.8% of them [71].”
From Chitosan Hemostatic Dressings: Properties and Surgical Applications (2024) · cites this paper as [71]
In the citing paper
“The results showed that primary technical success was achieved in 91.7% of patients, with adequate hemostasis achieved after around 8.9 (±3.9) min and ambulation occurring after 462 (±199) min.”
From Chitosan Hemostatic Dressings: Properties and Surgical Applications (2024) · cites this paper as [71]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“five (4.1%) pseudoaneurysms”
§ Efficacy and Safety of Axiostat® Hemostatic Dressing in Aiding Manual Compression Closure of the Femoral Arterial Access Site in Patients Undergoing Endovascular Treatments: A Preliminary Clinical Experience in Two Centers > 3. Results > 3.3. Outcomes
Reported 4.1 · recomputed 4.166667
Citations
Cites
Use of chitosan as a biomaterial: Studies on its safety and hemostatic potential
Rao, S. B., & Sharma, C. P. (1997) · Journal of Biomedical Materials Research · doi:10.1002/(sici)1097-4636(199701)34:1<21::aid-jbm4>3.0.co;2-p · Cited by 767
Filippiadis, D. K., Binkert, C., Pellerin, O., Hoffmann, R. T., Krajina, A., & Pereira, P. L. (2017) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-017-1703-4 · Cited by 720
Stoner, M. C., Calligaro, K. D., Chaer, R. A., Dietzek, A. M., Farber, A., Guzman, R. J., Hamdan, A. D., Landry, G. J., & Yamaguchi, D. J. (2016) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2016.03.420 · Cited by 459
Nikolsky, E., Mehran, R., Halkin, A., Aymong, E. D., Mintz, G. S., Lasic, Z., Negoita, M., Fahy, M., Krieger, S., Moussa, I., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.06.048 · Cited by 439
Lincoff, A. M. (2004) · JAMA · doi:10.1001/jama.292.6.696 · Cited by 401
Dangas, G., Mehran, R., Kokolis, S., Feldman, D. N., Satler, L. F., Pichard, A. D., Kent, K. M., Lansky, A. J., Stone, G. W., & Leon, M. B. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01449-8 · Cited by 242
Malette, W. G., Quigley, H. J., Gaines, R. D., Johnson, N. D., & Rainer, W. G. (1983) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(10)60649-2 · Cited by 213
Nikolsky, E., Halkin, A., Mehran, R., Krieger, S., Aymong, E. A., Lasić, Z., Negoita, M., Sulaiman, R., da Costa, R. A., Moses, J. W., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(04)90262-8 · Cited by 205
Kussmaul, W. G., Buchbinder, M., Whitlow, P. L., Aker, U. T., Heuser, R. R., King, S. B., Kent, K. M., Leon, M. B., Kolansky, D. M., & Sandza, J. G. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00101-9 · Cited by 202
Schulz-Schüpke, S., Helde, S., Gewalt, S., Ibrahim, T., Linhardt, M., Haas, K., Hoppe, K., Böttiger, C., Groha, P., Bradaric, C., et al. (2014) · JAMA · doi:10.1001/jama.2014.15305 · Cited by 198
Loffroy, R., Guiu, B., D'Athis, P., Mezzetta, L., Gagnaire, A., Jouve, J., Ortega–Deballon, P., Cheynel, N., Cercueil, J., & Krausé, D. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.02.003 · Cited by 159
Baim, D. S., Knopf, W. D., Hinohara, T., Schwarten, D. E., Schatz, R. A., Pinkerton, C. A., Cutlip, D. E., Fitzpatrick, M., Ho, K. K. L., & Kuntz, R. E. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00882-6 · Cited by 129
Martin, J. L., Pratsos, A., Magargee, E., Mayhew, K., Pensyl, C., Nunn, M. C., Day, F., & Shapiro, T. A. (2007) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.21333 · Cited by 118
Wong, S. C., Bachinsky, W., Cambier, P. A., Stoler, R., Aji, J. I., Rogers, J. H., Hermiller, J. B., Nair, R., Hutman, H., & Wang, H. (2009) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2009.06.006 · Cited by 112
Vascular closure devices for femoral arterial puncture site haemostasis
Robertson, L., Andras, A., Colgan, F. E., & Jackson, R. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009541.pub2 · Cited by 108
CIRSE Standards of Practice on Hepatic Transarterial Chemoembolisation
Lucatelli, P., Burrel, M., Guiu, B., de Rubeis, G., van Delden, O., & Helmberger, T. (2021) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-021-02968-1 · Cited by 101
CIRSE Standards of Practice on Bronchial Artery Embolisation
Kettenbach, J., Ittrich, H., Gaubert, J. Y., Gebauer, B., & Vos, J. A. (2022) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-022-03127-w · Cited by 93
Hadi, M., Walker, C., Desborough, M., Basile, A., Tsetis, D. K., Hunt, B. J., Müller-Hüllsbeck, S., Rand, T., van Delden, O. M., & Uberoi, R. (2021) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-020-02763-4 · Cited by 86
Percutaneous Treatment of Vascular Access-Site Complications: A Ten Years’ Experience in Two Centres
Minici, R., Paone, S., Talarico, M., Zappia, L., Abdalla, K., Petullà, M., & Laganà, D. (2020) · CVIR Endovascular · doi:10.1186/s42155-020-00120-7 · Cited by 43
Self-citationA Comparison of 2 Devices for Radial Artery Hemostasis After Transradial Coronary Intervention
Dai, N., Xu, D., Hou, L., Peng, W., Wei, Y., & Xu, Y. (2014) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0000000000000115 · Cited by 41
The SEAL Trial Study Team (2002) · American Heart Journal · doi:10.1067/mhj.2002.121464 · Cited by 34
Kang, S., Han, D., Kim, S., Yoon, C., Park, J.-J., Suh, J., Cho, Y., Youn, T., & Chae, I. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181099 · Cited by 33
Munich, S. A., Vakharia, K. V., McPheeters, M. J., Waqas, M., Tso, M. K., Levy, E. I., Snyder, K. V., Siddiqui, A. H., & Davies, J. M. (2020) · Operative Neurosurgery · doi:10.1093/ons/opaa230 · Cited by 33
Pang, N., Gao, J., Zhang, B., Guo, M., Zhang, N., Sun, M., & Wang, R. (2022) · Cardiovascular Therapeutics · doi:10.1155/2022/8569188 · Cited by 32
Sekhar, A., Sutton, B. S., Raheja, P., Mohsen, A., Anggelis, E., Anggelis, C. N., Keith, M. C. L., Dawn, B., Straton, S. L., & Flaherty, M. P. (2016) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2016.09.002 · Cited by 29
Noguchi, T., Miyazaki, S., Yasuda, S., Baba, T., Sumida, H., Morii, I., Daikoku, S., Goto, Y., & Nonogi, H. (2000) · European Journal of Vascular and Endovascular Surgery · doi:10.1053/ejvs.1999.1071 · Cited by 28
Roberts, J. S., Niu, J., & Pastor-Cervantes, J. A. (2019) · Cardiovascular Revascularization Medicine · doi:10.1016/j.carrev.2018.11.026 · Cited by 28
Minici, R., Ammendola, M., Manti, F., Siciliano, M. A., Minici, M., Komaei, I., Currò, G., & Laganà, D. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.634087 · Cited by 28
Self-citationMinici, R., Venturini, M., Fontana, F., Guzzardi, G., Pingitore, A., Piacentino, F., Serra, R., Coppola, A., Santoro, R., & Laganà, D. (2023) · Medicina · doi:10.3390/medicina59040710 · Cited by 28
Self-citationSharma, S., Kale, T. P., Balihallimath, L. J., & Motimath, A. (2017) · The Journal of Contemporary Dental Practice · doi:10.5005/jp-journals-10024-2130 · Cited by 24
Minici, R., Serra, R., Giurdanella, M., Talarico, M., Siciliano, M. A., Carrafiello, G., & Laganà, D. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13040640 · Cited by 24
Self-citationJakobsen, L., Holm, N. R., Mæng, M., Thim, T., Kristensen, S. D., Mogensen, L. J. H., & Christiansen, E. H. (2022) · BMC Cardiovascular Disorders · doi:10.1186/s12872-022-02512-0 · Cited by 23
Minici, R., Mercurio, M., Iannò, B., Galasso, O., Gasparini, G., & Laganà, D. (2023) · Healthcare · doi:10.3390/healthcare11050724 · Cited by 22
Self-citationEffects of sildenafil on right ventricle remodelling in Portopulmonary hypertension
Rossi, R., Talarico, M., Schepis, F., Coppi, F., Sgura, F. A., Monopoli, D. E., Minici, R., & Boriani, G. (2021) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2021.102071 · Cited by 21
Self-citationCIRSE Vascular Closure Device Registry
Reekers, J. A., Müller-Hülsbeck, S., Libicher, M., Atar, E., Trentmann, J., Goffette, P., Borggrefe, J., Zeleňák, K., Hooijboer, P., & Belli, A.-M. (2011) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-010-0004-y · Cited by 20
Gewalt, S. M., Helde, S. M., Ibrahim, T., Mayer, K., Schmidt, R., Bott-Flügel, L., Hoppe, K., Ott, I., Hieber, J., Morath, T., et al. (2018) · Circulation: Cardiovascular Interventions · doi:10.1161/circinterventions.117.006074 · Cited by 19
CIRSE Standards of Practice on Below-the-Knee Revascularisation
Spiliopoulos, S., Del Giudice, C., Manzi, M., Reppas, L., Rodt, T., & Uberoi, R. (2021) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-021-02891-5 · Cited by 19
Pathan, A. Z., Aijaz, S., Sheikh, S. S., & Sattar, S. (2021) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.29578 · Cited by 18
Minici, R., Ammendola, M., Manti, F., Siciliano, M. A., Giglio, E., Minici, M., Melina, M., Currò, G., & Laganà, D. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.634084 · Cited by 17
Self-citationMinici, R., Ammendola, M., Talarico, M., Luposella, M., Minici, M., Ciranni, S., Guzzardi, G., & Laganà, D. (2021) · CVIR Endovascular · doi:10.1186/s42155-021-00256-0 · Cited by 16
Self-citationThoracic endovascular repair for blunt traumatic thoracic aortic injury: Long-term results
Minici, R., Serra, R., Ierardi, A. M., Petullà, M., Bracale, U. M., Carrafiello, G., & Laganà, D. (2022) · Vascular · doi:10.1177/17085381221127740 · Cited by 15
Self-citationBRACALE, U. M., PELUSO, A., PANAGROSSO, M., CECERE, F., DEL GUERCIO, L., MINICI, R., GIANNOTTA, N., IELAPI, N., LICASTRO, N., SERRAINO, G. F., et al. (2022) · Chirurgia · doi:10.23736/s0394-9508.22.05381-5 · Cited by 15
Self-citationMinici, R., Serra, R., Rosi, N. D., Ciranni, S., Talarico, M., Petullà, M., Guzzardi, G., Fontana, F., & Laganà, D. (2023) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.30654 · Cited by 14
Self-citationPieper, C. C., Thomas, D., Nadal, J., Willinek, W. A., Schild, H. H., & Meyer, C. H. (2015) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-015-1204-2 · Cited by 13
Femoral vascular access for endovascular resuscitation
Manning, J. E., Moore, E. E., Morrison, J. J., Lyon, R. F., DuBose, J. J., & Ross, J. D. (2021) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000003339 · Cited by 13
Rossi, R., Talarico, M., Pascale, A., Pascale, V., Minici, R., & Boriani, G. (2022) · Diagnostics · doi:10.3390/diagnostics12112572 · Cited by 13
Self-citationEldibany, R. M. (2014) · Tanta Dental Journal · doi:10.1016/j.tdj.2014.04.002 · Cited by 12
Transcatheter Arterial Embolization (TAE) in the Management of Bleeding in the COVID-19 Patient
Minici, R., Fontana, F., Venturini, M., Guzzardi, G., Siciliano, A., Piacentino, F., Serra, R., Coppola, A., Guerriero, P., Apollonio, B., et al. (2023) · Medicina · doi:10.3390/medicina59061062 · Cited by 12
Self-citationKabeer, M., Venugopalan, P. P., & Subhash, V. C. (2019) · Cureus · doi:10.7759/cureus.5527 · Cited by 11
Anchan, R. K., Venturini, J., Larsen, P., Lee, L., Fernandez, C. M., Besser, S. A., Kalathiya, R., Paul, J., Blair, J. E., & Nathan, S. (2021) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.29529 · Cited by 11
CIRSE Standards of Practice on Arterial Access for Interventions
Memarian, S., Krokidis, M., O’Sullivan, G., Peynircioglu, B., Rossi, M., & Kashef, E. (2023) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-022-03349-y · Cited by 11
Freitas, B., Steiner, S., Bausback, Y., Staab, H., Branzan, D., Banning‑Eichenseer, U., Schmidt, A., & Scheinert, D. (2018) · The Journal of Cardiovascular Surgery · doi:10.23736/s0021-9509.16.09207-7 · Cited by 10
Chivot, C., Deramond, H., Bouzerar, R., & Yzet, T. (2018) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2018.02.014 · Cited by 9
Femoral artery access site closure with perclose suture mediated device in coronary interventions
Bhat, K. G., Kumar, R., Dabas, A. K., Chadha, D. S., Swamy, A. J., & Chadha, A. S. (2020) · Indian Heart Journal · doi:10.1016/j.ihj.2020.12.014 · Cited by 8
RAJENDRA, K., VEMPALLI, S., KADIYALA, M., SHARMA, V., KARIPINENI, S., GUNTURU, S., & PATIL, D. B. (2021) · National Journal of Maxillofacial Surgery · doi:10.4103/njms.njms_270_20 · Cited by 8
Owens, J. S., Bhatty, S., Donovan, R., Tordini, A., Danyi, P., Patel, K. P., Wegelin, J. A., & Jovin, I. S. (2017) · International Journal of Angiology · doi:10.1055/s-0037-1607037 · Cited by 6
Aijaz, S., Sheikh, S. S., & Pathan, A. Z. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-042101 · Cited by 6
Pate, G. E., & Broderick, B. (2011) · PubMed · Cited by 5
Wang, Z., Li, X., Chen, J., Shi, H., Pan, J., Zhang, X., & Jin, Z. (2013) · Clinical Radiology · doi:10.1016/j.crad.2013.04.001 · Cited by 3
Gedney, R., Villacreses, C. F., Wooster, M. D., & Genovese, E. A. (2023) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2022.11.005 · Cited by 2
(2004) · PubMed
(2015) · PubMed
Cited by
Chitosan Hemostatic Dressings: Properties and Surgical Applications
Cassano, R., Perri, P., Scarcello, E., Piro, P., Sole, R., Curcio, F., & Trombino, S. (2024) · Polymers · doi:10.3390/polym16131770 · Cited by 77
Transcatheter Arterial Embolization (TAE) of Cancer-Related Bleeding
Minici, R., Guzzardi, G., Venturini, M., Fontana, F., Coppola, A., Spinetta, M., Piacentino, F., Pingitore, A., Serra, R., Costa, D., et al. (2023) · Medicina · doi:10.3390/medicina59071323 · Cited by 37
Self-citationRecent Applications of Chitosan-Based Biomaterials as Wound Dressings
Jin, S. G. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27041637 · Cited by 29
Duymaz, D., Kebabci, A. O., & Kızılel, S. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.142055 · Cited by 20
Minici, R., Mercurio, M., Guzzardi, G., Venturini, M., Fontana, F., Brunese, L., Guerriero, P., Serra, R., Piacentino, F., Spinetta, M., et al. (2023) · Tomography · doi:10.3390/tomography9050133 · Cited by 16
Self-citation
Metadata
- Authors
- Minici, R., Serra, R., Maglia, C., Guzzardi, G., Spinetta, M., Fontana, F., Venturini, M., & Laganà, D.
- Affiliations
- Azienda Ospedaliero-Universitaria "Renato Dulbecco" (IT)
- Magna Graecia University (IT)
- Azienda Ospedaliero Universitaria Maggiore della Carita (IT)
- University of Insubria (IT)
- Corresponding author
- Laganà, Domenico
- ORCID
- Venue
- Journal of Personalized Medicine
- Publisher
- MDPI AG
- Published
- 2023-05-11
- Volume
- 13
- Issue
- 5
- Pages
- 812
- ISSN
- 2075-4426 (ISSN-L)
- PMC
- PMC10220903
- OpenAlex
- W4378515386
- Semantic Scholar
- a23afea1c3135aae57483898fe2b099b5ec332f3
- Cited by
- 20
- References
- 62
- Citations by year
- 2026: 6 · 2025: 6 · 2024: 3 · 2023: 5
- FWCI
- 3.11
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Personalized Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- IrInSubria (University of Insubria) (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Vascular Procedures and Complications
- Health Sciences › Medicine › Hematology › Hemostasis and retained surgical items
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Central Venous Catheters and Hemodialysis
- Keywords
- hemostasis, endovascular intervention, vascular closure devices, introducer sheath, bleeding complications, time to ambulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-17, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-17 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.